<!doctype html><html><head><meta charset=utf-8><title>MS Factoids</title>
<link rel=stylesheet href="/css/main.css?v=1753303881"><link rel=stylesheet href="/css/pagination.css?v=1753303881"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303881"></script><script src="/js/search.js?v=1753303881"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>MS Factoids</h1><time>February 23, 2012</time><div data-pagefind-body><h1 id=general-information-about-multiple-sclerosishttpwwwthemcfoxcommultiple-sclerosisms-factsmultiple-sclerosis-factshtm-from-the-mc-foxcom><a href=http://www.themcfox.com/multiple-sclerosis/ms-facts/multiple-sclerosis-facts.htm>General Information about Multiple Sclerosis</a> from the MC Fox.com</h1><h3 id=notelow-vitamin-d-increases-probability-of-ms-which-lowers-vitamin-d-levels-even-more--span-stylecolor00fvitamin-d-related-items-are-marked-in-bluespan->(Note:low vitamin D increases probability of MS which lowers vitamin D levels even more. <strong><span style=color:#00f>Vitamin D related items are marked in blue</span></strong> )</h3><ul><li><p>First Diagnosed in 1849</p></li><li><p>The earliest known description of a person with possible Multiple Sclerosis dates from 14th century Holland</p></li><li><p>Multiple Sclerosis is the most common progressive and disabling neurological condition in young adults</p></li><li><p>Approx 2.5 million people worldwide, have Multiple Sclerosis</p></li><li><p>Around 400,000 people in the United States have Multiple Sclerosis</p></li><li><p>In the UK, approx 70,000 people have the disease</p></li><li><p>Approx 50,000 people in Canada have Multiple Sclerosis</p></li><li><p>Scotland has the highest incidence of Multiple Sclerosis per head of population in the world <span style=color:#00f>also have the lowest levels of vitamin D in the world</span></p></li></ul><blockquote><p>In Scotland, over 10,500 people have Multiple Sclerosis</p></blockquote><ul><li><p>No virus has ever been isolated as the cause of Multiple Sclerosis</p></li><li><p>Average age of clinical onset is 30 – 33 years of age</p></li><li><p>The average age of diagnosis is 37 years of age</p></li><li><p>The average time between clinical onset of MS and diagnosis by physicians is 4 - 5 years</p></li><li><p>10% of cases are diagnosed after the age of fifty</p></li><li><p>In 1936, only 8% of patients were reported to survive beyond 20 years after onset of illness</p></li><li><p>In 1961, over 80% of Multiple Sclerosis patients were reported surviving to 20 years after onset of illness</p></li><li><p>2002 – A patient with Multiple Sclerosis can expect to live to average population life-expectancy minus seven years (mean life expectancy - 7 years)</p></li><li><p>Multiple Sclerosis is five times more prevalent in temperate climates than in tropical climates <a href=/tags/span-stylecolor00fwell-known-latitudeuvbspan.html><span style=color:#00f>well known latitude/UVB</span></a></p></li><li><p>Multiple Sclerosis affects women much more frequently than men. Approx. 1.7 – 2:1 in the US and approx 3:2 in the UK <span style=color:#00f>women have lower vitamin D levels than men</span></p></li><li><p>The ratio of white to non-white is approx 2:1</p></li><li><p>Gypsies and Inuit&rsquo;s do get Multiple Sclerosis although the incidence rate is much lower than other populations at approx 19 per 100,000</p></li><li><p>Native Indians of North and South America, the Japanese and other Asian peoples have a very low incidence rate of Multiple Sclerosis</p></li><li><p>In identical twins where one twin develops the disease, the likelihood of the second twin developing Multiple Sclerosis is approx 30%</p></li><li><p>The incidence rate for non-identical twins, where one contracts Multiple Sclerosis, is approx 4%</p></li><li><p>The risk of contracting Multiple Sclerosis if a first-degree relative (father, mother, sibling) has the disease, is approx 1% - 3% overall</p></li><li><p>The risk of contracting Multiple Sclerosis if your father has the disease is approx 1 in 100</p></li><li><p>The risk of contracting Multiple Sclerosis if your mother has the disease is approx 1 in 50</p></li><li><p>The risk among the general population of contracting Multiple Sclerosis is approx 1 in 800</p></li></ul><h1 id=multiple-sclerosis-symptoms-from-same-group>Multiple Sclerosis symptoms from same group</h1><ul><li><p>The symptoms of Multiple Sclerosis may be mild or severe, chronic (long-term) or of short duration; may be transient (appear and disappear very quickly)</p></li><li><p>Symptoms and signs may disappear or may fluctuate in character and intensity</p></li><li><p>The sometimes bizarre and transient nature of symptoms may be mistaken for a psychiatric condition</p></li><li><p>Approx. 40% of Multiple Sclerosis patients have Relapsing-Remitting Multiple Sclerosis (RRMS)</p></li><li><p>Approx. 20% of Multiple Sclerosis patients will initially be diagnosed as having Benign Multiple Sclerosis</p></li></ul><blockquote><p>Less than 5% - 10% of patients actually have benign Multiple Sclerosis</p></blockquote><ul><li><p>55% of patients with Multiple Sclerosis will develop optic neuritis at some time or other during their lifetime. 45% of patients do not</p></li><li><p>Approximately 5% - 10% of Multiple Sclerosis patients experience trigeminal neuralgia (tic delaroux) at some stage during the course of the disease</p></li><li><p>Only 15% of patients with Multiple Sclerosis will have optic neuritis as a first symptom. 85% will present to their physician with a different symptom</p></li><li><p>Between 20% - 40% of women with Multiple Sclerosis have a relapse within the 3 months post partum (after giving birth) <a href=/tags/span-stylecolor00fvitamin-d-levels-are-lowest-after-birthspan.html><span style=color:#00f>vitamin D levels are lowest after birth</span></a></p></li><li><p>Complete or partial remission of symptoms will occur in approx 70% of patients, particularly during the early stages of the disease</p></li><li><p>Males have a higher tendency to develop Primary Progressive Multiple Sclerosis (PPMS)</p></li><li><p>Females tend to experience more relapses than men</p></li><li><p>5% of Multiple Sclerosis patients exhibit an inappropriate euphoria</p></li><li><p>Approx 50% of patients with Multiple Sclerosis experience cognitive impairment such as difficulty with concentration, attention, memory and poor judgment <a href=/tags/span-stylecolor00flow-cognition-is-associated-with-low-vitamin-dspan.html><span style=color:#00f>Low cognition is associated with low vitamin D</span></a></p></li><li><p>Approx 50% of Multiple Sclerosis patients will suffer some form of mental disturbance such as depression, mild dementia or organic psychosis</p></li><li><p>2/3 of patients with Multiple Sclerosis will develop disturbance of sphincter control at some stage during the course of the disease</p></li><li><p>The major bowel complaint is constipation although fecal incontinence may occur occasionally in some patients</p></li><li><p>Depression is common and unrelated to cognitive impairment although it may worsen existing cognitive difficulties <a href="https://www.VitaminDWiki.com/tiki-browse_categories.php?parentId=48&amp;sort_mode=created_desc"><span style=color:#00f>SAD is associated with low level of vitamin D</span></a></p></li><li><p>Approx 10% of patients with Multiple Sclerosis will suffer severe psychotic disorders such as Manic Depression (Bipolar Disorder) and paranoia</p></li><li><p>In approx 80% of Multiple Sclerosis sufferers, heat will cause a temporary worsening of symptoms (Uhthoff&rsquo;s Phenomenon).</p></li></ul><blockquote><p>The heat source may be externally produced, for example, a hot bath; or the result of physical exertion.</p></blockquote><blockquote><p>Removal of the heat source / cooling normally, though not always, eliminates the problem, although this can take from a few minutes to several hours.</p></blockquote><ul><li><p>60% of neurological signs experienced during hyperthermia (i.e. Uhthoff&rsquo;s phenomenon) are new to the patient.</p></li><li><p>Some heat sensitive patients find a cool bath or swimming temporarily relieves some symptoms</p></li><li><p>Relapsing-remitting Multiple Sclerosis patients develop, on average, 20 new lesions per year and will have between 1 – 2 exacerbations per year</p></li><li><p>For every 8 – 10 new lesions shown by MRI, only 1 clinical manifestation (measurable exacerbation) will occur</p></li><li><p>Patients with Primary Progressive Multiple Sclerosis have a higher incidence of spinal cord lesion and exhibit much more rapid development of disability than those with other forms of the disease</p></li><li><p>1 in every 4, or 25%, of exacerbations are associated with a viral infection</p></li><li><p>Approx 75% - 85% of patients with Relapsing Remitting Multiple Sclerosis (RRMS) will go on to develop Secondary Progressive Multiple Sclerosis (SPMS)</p></li><li><p>Approx 80% of patients with Multiple Sclerosis experience fatigue Vitamin D deficiency is strongly associated with <a href=/tags/fatigue.html>Fatigue</a></p></li><li><p>Spasticity will occur in approx 60% of patients with a progressive form of the disease</p></li><li><p>80% - 90% of men and 45% - 70% of women will report some form of sexual dysfunction</p></li><li><p>Patients with Multiple Sclerosis have a greater risk of seizure than in the general population <a href=/tags/span-stylecolor00fseizures-are-associated-with-low-level-of-vitamin-dspan.html><span style=color:#00f>Seizures are associated with low level of vitamin D</span></a></p></li><li><p>Lesions may occur in the Corpus Callosum, an area of the brain thought to be involved in seizures</p></li><li><p>Exercises or physical therapy designed to stretch the muscles, particularly those of the leg, can help prevent contractures, an irreversible shortening of muscles.</p></li></ul><h1 id=see-vitamindwiki>See VitaminDWiki</h1><ul><li><a href=/posts/overview-ms-and-vitamin-d>Overview MS and vitamin D</a></li></ul></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/autoimmune.html><span class=tag>autoimmune</span></a>
<a href=/tags/bipolar-disorder.html><span class=tag>bipolar disorder</span></a>
<a href=/tags/brain.html><span class=tag>brain</span></a>
<a href=/tags/cognitive.html><span class=tag>cognitive</span></a>
<a href=/tags/dementia.html><span class=tag>dementia</span></a>
<a href=/tags/depression.html><span class=tag>depression</span></a>
<a href=/tags/high-dose.html><span class=tag>high dose</span></a>
<a href=/tags/intervention.html><span class=tag>intervention</span></a>
<a href=/tags/mood-disorders.html><span class=tag>mood disorders</span></a>
<a href=/tags/multiple-sclerosis.html><span class=tag>multiple sclerosis</span></a>
<a href=/tags/multiple-sclerosis.html><span class=tag>Multiple Sclerosis</span></a>
<a href=/tags/neurological.html><span class=tag>neurological</span></a>
<a href=/tags/sad.html><span class=tag>SAD</span></a>
<a href=/tags/spinal-cord.html><span class=tag>spinal cord</span></a>
<a href=/tags/therapeutic-intervention.html><span class=tag>therapeutic intervention</span></a>
<a href=/tags/virus.html><span class=tag>virus</span></a>
<a href=/tags/virus-and-cognitive.html><span class=tag>virus and cognitive</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a>
<a href=/tags/vitamin-d-and-viruses.html><span class=tag>vitamin d and viruses</span></a></div><div data-pagefind-meta=tags hidden>autoimmune, bipolar disorder, brain, cognitive, dementia, depression, high dose, intervention, mood disorders, multiple sclerosis, Multiple Sclerosis, neurological, SAD, spinal cord, therapeutic intervention, virus, virus and cognitive, vitamin d, vitamin d and viruses</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303881"></script><script src="/js/tiki-redirects.js?v=1753303881"></script><script src="/js/lightspa.js?v=1753303881"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303881",indexUrl:"/search/search_index.json.gz?v=1753303881"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303881"></script></body></html>